Pharmaceutical Technology, Sep 1, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Sep 1, 2009
Articles
Using Microreactors in Chemical Synthesis: Batch Process versus Continuous Flow
By Andreas Weiler , Matthias Junkers
The authors discuss the advantages of microreactors and flow chemistry for various reaction types in achieving improved process economics and reaction efficiency.
Moving from Vial to Prefilled Syringe
By Raul Soikes
A Project Manager's Perspective.
Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
By Rosie McLaughlin , Susan Banbury , Kieran Crowley
The authors describe the various available technologies used in orally disintegrating tablets.
Market Outlook for Biosimilars
By Bornadata Bain
The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.
Applying Biocatalysis: A Technical Forum
By Patricia Van Arnum
Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum.
Design and Construction of a Potent Pharmaceutical CGMP Suite
By Joe Cascone
The author describes the approach taken to develop a facility dedicated to handling potent and cytotoxic drug substances.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here